General Announcement::ANDA approval for HAILEYTM 24 Fe and Ferrous Fumarate Tablets), 1 mg/20 mcg

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
20-Nov-2017 12:43:37
Status
New
Announcement Sub Title
ANDA approval for HAILEYTM 24 Fe and Ferrous Fumarate Tablets), 1 mg/20 mcg
Announcement Reference
SG171120OTHRL3Z5
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
20/11/2017 10:00:00
Description (Please provide a detailed description of the event in the box below)
Sub: Glenmark Pharmaceuticals receives ANDA approval for HAILEYTM 24 Fe (Norethindrone Acetate and Ethinyl Estradiol Tablets, USP and Ferrous Fumarate Tablets), 1 mg/20 mcg.

With reference to the subject mentioned above, kindly find attached media release which is self-explanatory.

Request you to kindly take the same on record.

Attachments

PR2011_SGX.pdf
Total size =465K